Units vs. Milligrams: The Dosing Confusion That Puts Peptide Users at Risk

Why This Is the #1 Safety Issue in Peptide Communities Right Now

In the past week, a post titled something like "reminder: units are not milligrams" accumulated 304 upvotes in r/Peptides — one of the most visible communities for research peptide discussion. That number is significant. It reflects widespread recognition that a specific, concrete, avoidable calculation error is happening repeatedly, at scale, in the research peptide space.

The error is this: someone draws a dose based on the numbers printed on an insulin syringe and assumes those numbers correspond directly to milligrams of peptide. They don't. The numbers on an insulin syringe measure a unit of liquid volume defined by the syringe type — not mass of any particular substance.

This distinction, when missed, does not produce a small dosing error. Depending on the specific circumstances, it can produce an error of 10x, 50x, or even larger. For potent peptides — particularly GLP-1 receptor agonists like semaglutide and tirzepatide, where nausea, vomiting, and blood sugar effects are highly dose-dependent — a calculation error of this magnitude is a genuine medical emergency risk.

The good news is that this error is entirely preventable. Once you understand how insulin syringes work, what "units" actually means, and how to do the reconstitution math, the correct dose number becomes a straightforward calculation you can verify in about thirty seconds. That is what this guide covers.

This guide covers: how insulin syringes are calibrated; what "units" actually measures; the full reconstitution math with a worked example; a reference table for common reconstitution volumes; where community advice in units can silently go wrong; and which peptides carry the highest risk from this type of error.

An insulin syringe does not measure milligrams. It does not measure micrograms. It measures a unit of volume called — confusingly — a "unit," which is specific to insulin dosing conventions and varies by syringe type.

Here is the precise definition for the most common syringe type:

That is all a "unit" is on a U-100 syringe: a fraction of a milliliter. When you draw to the "10" mark on a U-100 syringe, you are drawing exactly 0.1 mL of liquid — regardless of what that liquid contains.

The amount of peptide in that 0.1 mL depends entirely on the concentration of your reconstituted solution — how much peptide (in mg or mcg) you dissolved per milliliter of bacteriostatic water. If your solution is 2.5 mg/mL, then 0.1 mL contains 0.25 mg. If your solution is 5 mg/mL, then 0.1 mL contains 0.5 mg.

The Dangerous Error

The dangerous error happens when someone thinks: "I need 10mg, so I'll draw to 10 units."

If the solution is 2.5 mg/mL, "10 units" (0.1 mL) delivers 0.25 mg — not 10 mg. The person intending 10 mg would actually need to draw to 400 units, which does not even fit in a standard syringe. The inverse error — drawing to 10 units thinking it delivers a small dose when the actual intended dose was in milligrams — produces an equally dangerous calculation breakdown.

This is further complicated by the way peptide doses are expressed. Many peptides are dosed in micrograms (mcg), not milligrams (mg). One milligram equals 1,000 micrograms. A 250 mcg dose is 0.25 mg. If a person confuses "mcg" and "mg" in addition to confusing "units" and "mg," the error compounds dramatically. Getting the units of measurement correct at every step of the calculation matters.

There are two main types of insulin syringes in circulation. Using the wrong type with the same dose calculation produces a significant dosing error.

U-100 Syringes (Standard — Use These)

U-100 is the current standard in the United States and most of the world. The "U-100" designation means the syringe is calibrated for insulin at a concentration of 100 units per mL. Every mark on the barrel represents 0.01 mL of volume.

U-40 Syringes (Older / Veterinary — Be Careful)

U-40 syringes are less common in the US today but appear in veterinary contexts and in some international markets. The calibration is different: 40 units = 1 mL, so 1 unit = 0.025 mL.

The rest of this guide assumes U-100 syringes throughout, as they are the standard for research peptide use in the US market. If you are using a different syringe type, adjust all calculations accordingly.

Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder in liquid — typically bacteriostatic water — to create an injectable solution. The amount of liquid you add determines the concentration of the resulting solution, which determines how many units to draw for any given dose.

Every correct dosing calculation starts here. There is no safe shortcut that skips this step.

Worked Example

Starting point: A 5 mg vial of lyophilized peptide. You add 2 mL of bacteriostatic water.

1. Calculate concentration: 5 mg ÷ 2 mL = 2.5 mg per mL
   This is the most important number. Write it on the vial label immediately.
2. Convert to mcg/mL (if your target dose is in micrograms):
   2.5 mg/mL × 1000 = 2500 mcg per mL
3. Determine your target dose: For this example, target dose = 250 mcg
4. Calculate volume needed:
   250 mcg ÷ 2500 mcg/mL = 0.10 mL
5. Convert volume to U-100 syringe units:
   0.10 mL × 100 units/mL = 10 units
   Draw to the "10" mark on a U-100 syringe.

This formula works for any peptide, any dose, and any reconstitution volume — as long as you are using a U-100 syringe and your concentration is in mcg/mL. If your dose is in mg rather than mcg, convert it first (multiply mg by 1000 to get mcg) before plugging into the formula.

What the Math Looks Like at Different Doses

Using the same 5 mg vial reconstituted with 2 mL BAC water (2.5 mg/mL = 2500 mcg/mL):

Common Reconstitution Volumes and the Concentrations They Produce

The concentration of your solution changes entirely depending on how much bacteriostatic water you add to a given vial. Different reconstitution volumes are common for different reasons — smaller volumes produce more concentrated solutions that require drawing less liquid per dose; larger volumes produce more dilute solutions that allow finer precision on small doses.

This table shows the concentrations produced by common reconstitution combinations, and how many U-100 units correspond to a 250 mcg dose at each concentration.

These are patterns that appear repeatedly in community reports and are consistent with the calculation errors described above. They are framed as educational patterns, not as specific incidents.

Pattern 1: Overdose of a GLP-1 Peptide

Someone targets a weekly semaglutide dose in line with community guidance. They calculate based on units but have a different reconstitution concentration than the community post assumed. They draw twice the intended dose. Within hours: severe nausea, repeated vomiting, inability to keep food or water down, significant abdominal pain. If blood glucose drops — either because of the peptide's mechanism or because vomiting has prevented any food intake — hypoglycemia risk becomes real.

GLP-1 agonists can cause hypoglycemia, particularly when combined with low food intake or in people with pre-existing glucose regulation issues. Severe vomiting from a high GLP-1 dose creates exactly this combination. Dehydration from prolonged vomiting can require IV fluids.

Pattern 2: Persistent Underdose Leading to Dose Escalation

Someone draws what they believe is a therapeutic dose but has used a more concentrated reconstitution than community norms assume. Their effective dose is a fraction of what they believe they are taking. No effects. They conclude the peptide doesn't work — or worse, they escalate the amount they draw, using trial-and-error to find an "effective" amount. They find it — but now have no accurate record of what they are actually taking in concentration terms. Later, if they reconstitute a new vial differently, the same syringe mark delivers a wildly different dose.

This pattern is insidious because it does not produce an acute harm in the initial underdose phase. It creates a dosing log that is meaningless and a habit of not doing the math — which sets up the more dangerous error later.

Pattern 3: Incorrect BAC Water Volume

Someone plans to add 2 mL of BAC water to a 5 mg vial but accidentally adds 1 mL. They do not notice. Their solution is now 5 mg/mL rather than 2.5 mg/mL — twice as concentrated. Every subsequent dose delivers twice what they intended. The only way to catch this error is to label the vial immediately upon reconstitution with both the date and the concentration you calculated, verify the amount added before sealing, and re-do the concentration math before drawing any dose from a new vial.

Pattern 4: Mcg/mg Unit Confusion Compounding the Error

A community recommendation says "dose 250 units." A reader unfamiliar with the convention interprets this as 250 mcg — which requires figuring out the syringe math — but a second reader interprets "250 units" as the literal syringe mark. A third reader interprets the post as recommending 250 mg. These three interpretations are orders of magnitude apart. Community shorthand is not always written with enough precision to be unambiguous to everyone reading it.

Why Community Doses in Units Are Context-Dependent

Reddit peptide communities frequently give doses expressed in units rather than milligrams or micrograms. This is practical — it tells you exactly where to draw the syringe — but it only works if your reconstitution matches the one the post implicitly assumes.

When someone posts "I dose 10 units of semaglutide weekly," that post implicitly assumes a specific reconstitution. Most community norms around GLP-1 peptides assume something like a 2 mg/mL or 2.5 mg/mL solution. If your reconstitution is different, "10 units" is not the right number for you.

The correct procedure when encountering a unit-based community recommendation:

1. Identify the implicit reconstitution assumption (sometimes it is stated; often it is not, and you may need to ask).
2. Calculate the mg or mcg dose that the recommendation corresponds to at that assumed concentration.
3. Use your own concentration to calculate how many units deliver that mg/mcg dose from your vial.

This is not complicated, but it requires doing the math explicitly rather than copying a number. For the same reason, if you change your reconstitution volume between vials — adding more or less BAC water than last time — your unit doses change even though your target mg/mcg dose stays the same.

Practical Tools and Habits That Prevent Dosing Errors

Dosing errors in the research peptide context are almost always preventable. The following practices, taken together, make the most common error patterns nearly impossible.

Label Vials Immediately and Completely

The single most effective habit. Every vial, the moment it is reconstituted, should have a label that includes:

• Peptide name and source vial size (e.g., "Semaglutide 5 mg")
• Volume of BAC water added (e.g., "2 mL BAC water")
• Resulting concentration (e.g., "2.5 mg/mL")
• Date reconstituted
• Discard-by date (typically 28 days from reconstitution when refrigerated)

With this label on the vial, you always know your concentration. You can recalculate the correct units for your target dose in seconds. You never have to guess or rely on what you thought you added last week.

Keep a Dosing Log

A simple written or digital log that records each dose — date, syringe units drawn, calculated dose in mg/mcg, any observations — serves two purposes. First, it catches errors: if your dose log shows that you have been drawing wildly different unit amounts across vials with the same labeled size, that discrepancy flags something to investigate. Second, it creates a meaningful record if you ever need to describe your use history to a healthcare provider.

The log does not need to be elaborate. A notes app on your phone with a few fields per dose entry is sufficient.

Verify the Syringe Type Before Drawing

If you have multiple syringe types — U-100 and U-40, or standard and insulin syringes — keep them physically separated and labeled. Before drawing any dose, confirm you have the correct syringe type. The calculation for a U-40 syringe is different from U-100, and mixing them produces a 2.5x dosing error.

Use an Online Calculator as a Cross-Check

Do your own math. Then run the same numbers through an online reconstitution calculator and confirm the results match. If they don't, identify the discrepancy before drawing. This takes about thirty seconds and catches arithmetic errors before they reach the syringe.

Measure BAC Water Carefully

Use a calibrated syringe or a precise volume measurement when adding BAC water to a vial. Drawing bacteriostatic water up "to about 2 mL" and calling it close enough introduces an error in your concentration calculation from the first step. A 1.8 mL addition when you calculated for 2 mL produces a concentration that is 11% higher than intended — not catastrophic, but compounding on top of other approximations.

Not all dosing errors carry the same risk. The severity of a calculation error depends on the potency of the compound, the steepness of its dose-response curve, and the specific adverse effects that dose-dependent errors are likely to produce. The following contexts carry the highest risk from units-vs-milligrams confusion.

GLP-1 Receptor Agonists: Semaglutide and Tirzepatide

These are the highest-risk category for this type of error for two reasons: first, they are the most widely used research peptides in this community right now, so the raw number of people making this calculation is large; second, their adverse effects are dose-dependent and can escalate to medically serious levels at higher doses.

GLP-1 agonist overdose produces:

• Severe nausea and vomiting, often for 12 to 24 hours or more
• Profound loss of appetite and inability to eat
• Risk of dehydration from extended vomiting
• Hypoglycemia risk, especially when food intake is severely reduced
• Potential pancreatitis at very high doses (documented in pharmaceutical literature at supratherapeutic doses)

These are not symptoms to manage at home while consulting Reddit. Severe GLP-1 overdose warrants clinical evaluation.

A specific risk with GLP-1 peptides: tirzepatide acts on both GLP-1 and GIP receptors, making it more potent per weight than semaglutide at comparable doses. Dosing math errors carry proportionally higher consequences.

Peptides Dosed in Micrograms With Narrow Windows

Many research peptides are dosed in the range of 100 to 500 mcg — one-tenth to one-half of a milligram. These small mass doses are well within the liquid volume range of a standard insulin syringe. But because the target dose is so small in weight terms, the units-vs-mcg-vs-mg confusion creates errors that span several orders of magnitude.

Consider: a target dose of 250 mcg. If someone mistakenly reads this as 250 mg — a thousandfold difference — and attempts to draw accordingly, no standard syringe can even hold that volume. But if the confusion is between mcg and units, the error is more subtle and the result more dangerous because it may be within the range the syringe can physically deliver.

Anything With Cardiovascular or Blood Pressure Effects

Several research peptides have dose-dependent cardiovascular effects — effects on heart rate, blood pressure, or vascular tone. Overdosing compounds in this category can produce tachycardia, hypertension, or in sensitive individuals, more significant cardiovascular stress. If you are using any peptide that has known cardiovascular effects in the published literature, dosing accuracy is not optional — it is a direct safety requirement.

While not the primary topic of this guide, the distinction between bacteriostatic water and sterile water for reconstitution is relevant enough to call out directly, because it affects the safety of multi-dose vials after reconstitution.

Bacteriostatic water (BAC water) contains 0.9% benzyl alcohol as a preservative. This preservative inhibits bacterial growth in the reconstituted solution, making it safe for multi-dose vials stored under refrigeration for approximately 28 days.

Sterile water for injection contains no preservative. It is sterile at the time of manufacture, but once a needle has been introduced into the vial, there is no antimicrobial protection. Each subsequent needle insertion into the vial introduces the potential for bacterial contamination. Sterile water is appropriate for single-use reconstitution — use the entire vial in one session — not for multi-dose storage.

One additional note: the benzyl alcohol in BAC water can cause a mild stinging sensation at the injection site in some individuals. This is normal and not an adverse reaction to the peptide. If stinging is a concern, some researchers use a 1:1 dilution of BAC water with sterile water to reduce the benzyl alcohol concentration while still maintaining some antimicrobial protection — though this shortens the safe storage window.

When to Seek Medical Care

If you have taken a research peptide dose and are experiencing any of the following, do not wait and see:

• Severe, repeated vomiting that prevents fluid intake for more than a few hours
• Signs of low blood sugar: shakiness, sweating, confusion, weakness, rapid heartbeat, pale skin
• Signs of an allergic reaction: hives, difficulty breathing, swelling of the face or throat
• Chest pain, palpitations, or significant changes in heart rate
• Severe abdominal pain (upper abdominal pain radiating to the back may indicate pancreatitis)
• Any rapidly worsening symptom

Frequently Asked Questions